BackgroundCheck.run
Search For

Morris A Kesselman Deceased2 April Springs Ct, Lakewood, NJ 08701

Morris Kesselman Phones & Addresses

2 April Springs Ct, Lakewood, NJ 08701   

Pikesville, MD   

600 5Th Ave, Belmar, NJ 07719   

Yonkers, NY   

8916 Griffin Way, Pikesville, MD 21208   

Mentions for Morris A Kesselman

Publications & IP owners

Us Patents

Stabilization Of Multivitamin/Trace Elements Formulations

US Patent:
4804535, Feb 14, 1989
Filed:
Feb 8, 1988
Appl. No.:
7/153182
Inventors:
Morris Kesselman - Belmar NJ
Abdur R. Purkaystha - Bronx NY
James Cahill - Richboro PA
Assignee:
Rorer Pharmaceutical Corporation - Fort Washington PA
International Classification:
A61K 3334
A61K 3107
A61K 31195
A61K 3144
US Classification:
424141
Abstract:
Disclosed are aqueous multivitamin/trace elements formulations stabilized by a water soluble, organic acid that contains carbon-to-carbon unsaturation and water soluble salts thereof selected from the group consisting of maleic acid, fumaric acid, maleamic acid and acrylic acid.

Stabilization Of Multivitamin/Trace Elements Formulations

US Patent:
4740373, Apr 26, 1988
Filed:
May 27, 1986
Appl. No.:
6/866842
Inventors:
Morris Kesselman - Belmar NJ
Abdur R. Purkaystha - Bronx NY
James Cahill - Riverdale NY
Assignee:
USV Pharmaceutical Corporation
International Classification:
A61K 3334
A61K 3107
A61K 31195
A61K 3144
US Classification:
424141
Abstract:
Disclosed are aqueous multivitamin/trace elements formulations stabilized by a water soluble, organic acid that contains carbon-to-carbon unsaturation and water soluble salts thereof selected from the group consisting of maleic acid, fumaric acid, maleamic acid and acrylic acid.

Celiprolol For The Treatment Of Glaucoma

US Patent:
4470965, Sep 11, 1984
Filed:
Oct 27, 1982
Appl. No.:
6/437072
Inventors:
Peter Wolf - Granite Springs NY
Morris A. Kesselman - Yonkers NY
Assignee:
USV Pharmaceutical Corporation - Tarrytown NY
International Classification:
A61K 3117
A61K 3179
US Classification:
424 80
Abstract:
An ophthalmic preparation for the treatment of glaucoma by the application to the glaucomatous eye of a celiprolol salt in a pharmaceutically acceptable ophthalmic carrier.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.